Request for Expression of Interest (REOI) for Pharmaceuticals, Minerals & Vitamins
Purchaser
UNICEF
Country
Multiple Destinations (See The Countries Or Territories Tab)
Published
7 May 2026
Closing date
31 May 2026
Source ID
Docs found
Unlock fit scoring for this notice, save it to your pipeline, and find similar public-sector opportunities that match your capabilities.
Source documents portal identified
Create a free account to continue to the source documents portal on mawaredmena.com.
- See whether this tender is worth pursuing.
- Keep this notice and your bid workflow in one workspace.
- Track similar tenders without rebuilding the search manually.
Summary
United Nations Children’s Fund (“UNICEF”), MENA Regional Office Request for Expression of Interest (REOI) for Pharmaceuticals, Minerals & Vitamins Date of Request for Expression of Interest (REoI): 7th May 2026 Closing date for receipt of REoI : 31st May 2026 Interested bidders are encouraged to submit their interest as early as possible and before the due date, as all responses will be reviewed on a rolling basis to determine next steps. UNICEF, MENA Regional Office (MENA) based in Amman, Jordan is requesting Expression of Interest from potential manufactures and suppliers of Pharmaceuticals and Mineral and Vitamins from countries based in MENA Region and Türkiye in preparation for a solicitation exercise for pharmaceutical products. Interested suppliers or manufacturers of pharmaceuticals, please read below the requirements and submit your expression of interest (REoI) by filling in the forms along with the documentation requested. Purpose of the REOI: This REoI is addressed to suppliers and manufacturers of pharmaceuticals and minerals and vitamins in the region for the supply of any of the listed pharmaceutical products. Description of requirements: S.No. Product List 1 Iron 60mg + Folic ac. 400mcg tab/PAC-100 2 Amoxicillin 250mg disp.tab/PAC-(10x10) 3 Iron 60mg+Folic ac.400mcg tab/PAC(10x10) 4 Albendazole 400mg chewable tabs/PAC-100 5 Amoxicillin 125mg/5ml pdr.or.s/BOT-100ml 6 Paracetamol 120mg/5ml or.liq/BOT-60ml 7 Co-Amoxiclav 125mg+ 31.25mg BOT/100ml 8 Co-Amoxiclav 500mg+125mg tabs/PAC3x5 9 Amoxicillin 500mg disp.tab/PAC-100 10 Paracetamol 500mg tabs/PAC-10x10 11 Ceftriaxone pdr/inj 1g vial/BOX-10 12 ORS low osm. 20.5g/1L CAR/10x10 13 ORS low osm. 15.4g/0.75L/CAR-10x10 14 Zinc 20mg tablets/PAC-10x10 15 Vitamin A (Retinol) 100,000IU caps / PAC 500 16 Vitamin A (Retinol) 200,000IU caps / PAC 500 17 Vitamin A (Retinol) 100,000IU caps 18 Vitamin A (Retinol) 200,000IU caps The REOI lists a total of 18 products, encompassing various formulations, strengths, and pack sizes. Over the past three years, pharmaceuticals have accounted for 52% of total expenditure, while Vitamin A represents 45% of spending within the Minerals and Vitamins category. While the above expenditure reflects spending for the MENA region, other countries from other region, as well as other international organizations and INGOs, may also piggyback on the procurement process conducted by UNICEF. Potential suppliers/manufacturers: UNICEF primarily globally purchases pharmaceuticals, minerals and vitamins directly from manufacturers and/or their authorized representatives. UNICEF MENA is particularly interested in identifying GMP qualified manufacturers with a Good Manufacturing Practice (GMP) Certificate issued by any stringent regulatory authority, PICS member or any of the following agencies: WHO, UNICEF, MSF or ICRC and/or suppliers with a Good Distribution Licence (GDP) for Medicines who procure & distribute pharmaceuticals from GMP qualified manufacturers for the items listed above for MENA Region. Potential suppliers/manufacturers are to indicate for the products of interest, all the packaging types and pack sizes they have available in their portfolios. To be considered for the planned tender it is preferable, but not a requirement, for potential suppliers to have a website providing access to the product information if available, and in addition to provide information as per Annex I and Annex II below. Please also provide information on the registration status of the medicines specifically in MENA Countries in addition to the other countries of registration of such as United Kingdom, European Union, United States of America, Australia or Canada etc. Procedure for submission of REOI: Interested suppliers/manufacturers are encouraged to indicate their interest by duly completing the Request for Expression of Interest (REoI) form via MawaredMENA Link - Mawared (refer link in the attached REOI word document). Please note: Prices are not required at this
Sign in to run AI fit scoring, bid/no bid reviews, and compliance drafting for this tender.